Tag: KEG

Blue Horseshoe Stocks: SDOC Recap & More


SandRidge Energy, Inc. SDOC

Our mention of SDOC in Friday’s premarket report turned out to very well-timed. We’ve had the stock on our radars since early this year, and  pushed it to the back burner for awhile, having so many other items of interest on the table.

We circled back around to it on Friday, just in time to catch a solid single session performance as the stock ran from a low of a nickel up to .0674; that works out to a 35% intraday increase on fairly heavy volume.

We’ll continue to keep an eye on SDOC, which appears to be ready to gap-up slightly today, for a breach of the 50DMA at .08.

Celldex Therapeutics, Inc. CLDX

We’re going to tag CLDX this morning as a bottom-watch play with serious rebound potential. Our bottom-feeder alerts are sounding loudly as we’re seeing the stock take an absolute nosedive on news of the cancellation of the company’s late-stage brain tumor vaccine study.

We’re always on the lookout for knee-jerk selloffs (which often transition into recovery plays), and CLDX has lost roughly half its value solely on the perceived effect of the announcement.

It’s worth it to mention that the company still has seven clinical trials underway on other products, so the discontinued project is by no means the only thing in the company’s pipeline.

We’ll be interested to track the action in CLDX in coming sessions as investors adjust to this morning’s events.

Extended Watchlist:
DCLT, PVAH, GDPM, WRES, LNCO, BBEP, CLF, KEG

Blue Horseshoe Stocks: PZOO News, Options & More

Voltari Corp. VLTC

Leading into this week, VLTC had been under consolidation following its epic run to new 52-week highs earlier in April. On Wednesday, the stock ultimately found support at 8.14 and by the time it had reached its daily high yesterday the stock had rebounded back to 11.65, a 43% swing.

VLTC did maintain the majority of its daily gains into the close yesterday. and this morning the stock is gapping up quite substantially with a premarket high of 12.34 already having printed.

There appears to be a key area of resistance around $14, and we’ll want to see VLTC hold support at or above its recent swing low of 8.14 on any pullbacks, in order to keep our interest.

Fresh Options Ideas:

We’ve got a few candidates for potential options trades as we close out the week. Please note that we’re referring to Weekly Calls which are on the cusp of expiration, so these would be for quick-trigger daytrades only. For swing trades into next week, one could look at 05/08 or 05/15 contracts.

Expedia, Inc. EXPE – $97-$99.50 Calls

FireEye, Inc. FEYE – $42-$43.50 Calls

Skyworks Solyutions, Inc. SWKS – $94.50-$96 Calls

Pazoo, Inc. PZOO

We want to touch base with PZOO this morning as we’re noticing a new PR hitting the wires. The stock consolidated for the first time in nearly a month this week, coming down off its recent high of .0204. Yesterday it held a penny as support and, we’ll want to see the stock maintain above that level as the week draws to a close.

TODAY’S NEWS:WHIPPANY, N.J., May 1, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that members of its staff will be attending several investment and marijuana conferences over the month of May. Pazoo is also pleased to announce it will have a booth at the 4th Annual Marijuana Business Conference and Expo, America’s largest national cannabis trade show, being held in Chicago, May 19-21.

With Pazoo’s family of companies about to begin operations, numerous Pazoo representatives will begin attending several upcoming marijuana conferences, with the first one in Chicago, Illinois, followed by a conference in Augusta, Maine. The Home Grown Maine trade show and expo, is New England’s largest and best Medical Marijuana Expo. Due to the greater than anticipated attendance from last year’s show, over 4,000 attendees, expo management changed locations to host this event in a larger facility to accommodate an expected exponential increase in the amount attendees expected for this year’s show…>>> FULL PR

Extended Watchlist:
OCN, JDST, LLNW, KEG, INO

Blue Horseshoe Stocks: FRO, OPK, WLGC & More

Frontline, Ltd. FRO

At the beginning of this month when we first began looking at FRO, the stock was trading at a low of 1.33. It took barely a week for the stock to start inching its way up, and it has continued to do so up to the present.

By the time we re-flagged it in Friday’s morning report, it had already cracked the $2.00-mark, and we did mention that the level of momentum was primed to allow for further opportunities.

This morning FRO continues to push the envelope, setting a new high in premarket trading action. This morning’s top figure of 2.64 puts us just slightly short of double-bagger status, having shown us an increase of 98% from the lows we observed the week before last.

It can be argued that the bolstering of activity seen on FRO (and other shipping plays) is due to the continuing fall of oil prices which translates to savings at the pump.

Opko Health, Inc. OPK

OPK is catching our attention in the premarket as well, as a result of an agreement announced this morning with pharma-giant Pfizer to develop and commercialize one of Opko’s highly promising products which combats Growth Hormone deficiency. Peruse the following PR to find out more; the development certainly lands OPK a spot on our watchlist to kick off the week.

In instances like these where a play is sent through the roof on substantial news, we look for the resulting profit-taking to pull the stock back, where we wait to take advantage of a possible dip-and-rip scenario.

OPKO Health, Inc. (OPK) and Pfizer Inc. (PFE) announced today that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD)… hGH-CTP has the potential to reduce the required dosing frequency of human growth hormone to a single weekly injection from the current standard of one injection per day. >> FULL PR

WordLogic Corp. WLGC

Speaking of significant news, WLGC forces its way into our vernacular this morning on the heels of the announcement that the company will be teaming up with energy-leviathan General Electric (GE) in order to “monetize specific patented intellectual property in General Electric’s portfolio.”

With such a high-profile bedfellow, WLGC will instantly gain new recognition, and it will be very interesting to see how that translates to the chart.

Notable Gainers from Friday’s Extended Watchlist

Oncothyreon, Inc. ONTY – Range: 1.69-2.05   Gain: 21%

Organovo Holdings, Inc. ONVO – Range: 5.82-6.50  Gain: 11%

Extended Watchlist:
TLM, SN, BLRX, KEG, HGSH, CPST